Page 5 - Mark Mcclellan News Today

Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds. But those drugs remain out of reach for millions

Medicare is prohibited from covering the high cost — but will that change?

Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.

WASHINGTON (AP) — New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions of<a class="excerpt-read-more" href="https://whdh.com/news/new-weight-loss-drugs-are-out-of-reach-for-millions-of-older-americans-because-medicare-wont-pay/">Read More</a>

Positive Encouraging K-LOVE

WASHINGTON (AP) — New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions

WASHINGTON (AP) -- New obesity drugs are showing promising results in helping some people shed pounds, but the injections will remain out of reach for millions of older Americans because Medicare is forbidden to cover such medications.

Despite its ban, the supplement androstenedione, or “andro,” is known for its many side effects. Androstenedione is a banned supplement, but that doesn't mean it's not still being used. Learn more about andro, including what it is, how it acts in the body and its dangerous side effects.

WASHINGTON (AP) — New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions

Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds. But those drugs remain out of reach for millions